Cystatin M/E prevents osteolytic bone disease by inhibiting cathepsin-dependent stages of osteoclastogenesis. Cystatin M/E prevents osteolytic bone disease by inhibiting cathepsin-dependent stages of osteoclastogenesis
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
To further determine how CST6 regulates osteoclast differentiation. Overall design: RNA sequencing were performed on in vitro osteoclastogenesis on control macrophages (without RANKL sitimulation), RANKL treatment for 48h, RANKL plus CST6 treatment for 48h.
创建时间：
2021-12-17
